Unknown PHASE3 INTERVENTIONAL 2-arm NCT02541708

IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania (Ferinject)

Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania

Sponsor: Ifakara Health Institute

Conditions Iron-Deficiency Anemia

Interventions Ferric carboxymaltose Ferrous sulfate + folic acid

Updated 8 times since 2017 Last updated: Apr 22, 2017 Started: Sep 30, 2015 Primary completion: Apr 30, 2018 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Iron-Deficiency Anemia and is currently ongoing. Ifakara Health Institute leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
May 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jun 2018 — May 2019 [monthly]

Active Not Recruiting PHASE3

▶ Show 3 earlier versions

Jun 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Feb 2017 — Jun 2017 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ifakara Health Institute
Swiss Tropical & Public Health Institute

Data source: Ifakara Health Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bagamoyo, Tanzania